Cyclosporine A nephrotoxicity: Role of thromboxane and reactive oxygen species

Journal of Laboratory and Clinical Medicine

Volumn 131, Issue 1, 1998, Pages 63-70

  Parra, Trinidad ^b   De Arriba, Gabriel ^a   Arribas, Ignacio ^b   Perez De Lema, Guillermo ^b   Rodriguez Puyol, Diego ^b   Rodriguez Puyol, Manuel ^b  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031886662     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90078-6     Document Type: Article

References (49)

1. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38.
2. Faulds D, Goa L, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993;45: 953-1040.
3. Mason J. The pathophysiology of Sandimmune (cyclosporine) in man and animals. Pediatr Nephrol 1990;4:554-74.
4. Cairns HS, Neild G. Cyclosporin nephrotoxicity. In: Cameron S, Davison AM, Grünfeld JP, et al, editors. Oxford textbook of clinical nephrology. Oxford: Oxford University Press, 1992:1560-9.
5. Thiel G. Experimental cyclosporine A nephrotoxicity. A summary of the international workshop. (Basel, April 24-26, 1985). Clin Nephrol 1986;25:S205-10.
6. Perico N, Zoja C, Benigni A, et al. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate. J Pharmacol Exp Ther 1986;239:229-35.
7. Dos Santos OF, Boim MA, Barros EJ, et al. Nephrotoxicity of cycloporine: the role of platelet- activating factor and thromboxane. Lipids 1991;26:1320-3.
8. Kon V, Sugiura M, Inagami T, Harvie B. Role of endothelin in cyclosporin-induced glomerular dysfunction. Kidney Int 1990; 37:1487-91.
9. Bloom IT, Bentley FR, Garrison RN. Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1. Surgery 1993;114:480-7.
10. Casas A. Hotter G, Roselló-Catafau J, et al. Prostanoids and cyclosporin-mediated nephrotoxicity in rats: a critical appraisal. Prostaglandins Leukot. Essent Fatty Acids 1995;52: 49-53.
11. Coffman TM, Carr DR, Yarger WE, Klotman PE. Evidence that renal prostaglandin and thromboxane production is stimulated in chronic cyclosporine nephrotoxicity. Transplantation 1987;43:282-5.
12. Perico N, Benigni A, Zoja C, et al. Functional significance of exaggerated renal thromboxane A2 synthesis induced by cyclosporin A. Am J Physiol 1986;251:F581-87.
13. Quereda C, Sabater J, Villafruela J, et al. Urinary thromboxane B2 and cyclic AMP in cyclosporine A-treated kidney transplantation. Transplant Proc 1994;26:2604-5.
14. Benigni A, Chiabrando C, Piccinelli A, et al. Increased urinary excretion of thromboxane B2 and 2,3-dinor-thromboxane B2 in Cyclosporin A nephrotoxicity. Kidney Int 1988;34: 164-74.
15. Bennet WM, Elzinga L, Kelley V. Pathophysiology of cyclosporine nephrotoxicity: role of the eicosanoids. Transplant Proc 1988;20:628-33.
16. Schnabel FR, Wait RB, Kahng KU. The relationship of urinary thromboxane excretion to cyclosporine nephrotoxicity. Transplantation 1991;51:686-9.
17. Teraoka S, Sanaka T, Takahashi K. et al. Stimulation of intrinsic prostacyclin synthesis and inhibition of thromboxane production to minimize cyclosporine nephrotoxicity. Transplant Proc 1988;20(Suppl.3):638-45.
18. Myers BD, Sibley R, Newton L. et al. The long-term course of cyclosporine associated chronic nephropathy. Kidney Int 1988;33: 590-600.
19. Kopp JB, Klotman PE. Cellular and molecular mechanisms of cyclosporin nephrotoxicity. J Am Soc Nephrol 1990;1:162-79.
20. Petric R, Freeman D, Wallace C, et al. Modulation of experimental cyclosporin nephrotoxicity by inhibition of thromboxane synthesis. Transplantation 1990;50:558-63.
21. Smeesters C, Chaland P, Giroux L, et al. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor. Transplant Proc 1988;20:663-9.
22. Gladue RP, Newborg MF. The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporin-treated rats. Transplantation 1991;52:837-41.
23. Grieve EM, Hawksworth GM, Simpson JG, Whiting PH. The reversal of experimental CyA nephrotoxicity by thromboxane synthetase inhibition. Biochem Pharmacol 1993;45:1351-4.
24. Perico N, Rossini M, Imberti O, et al. Thromboxane receptor blockade attenuates chronic cyclosporin nephrotoxicity and improves survival in rats with renal isograft. J Am Soc Nephrol 1992;2:1398-1404.
25. Bunke M, Wilder L, Martin A. Protection of glomerular filtration rate by thromboxane receptor antagonist L655,240 during low dose cyclosporin administration. Prostaglandins 1992;43:351-60.
26. Heberer M, Jorgensen J, Mihatsch MJ, Marx A, Landmann J. Protective effect of allopurinol and Superoxide dismutase in renal isografts in cyclosporin-A treated rats. Ren Fail 1991; 13:233-42.
27. Wang C, Salahudeen AK. Lipid peroxidation accompanies cyclosporin nephrotoxicity: effects of vitamin E. Kidney Int 1995;47:927-34.
28. Yoshimura R, Yoshimura N, Nakatani T, et al. The effects of cyclosporine on renal microsomal cytochrome P-450 systems. Clin Nephrol 1993;40:339-45.
29. Freeman BA, Crapo JD. Biology of disease. Free radicals and tissue injury. Lab Invest 1982;47:412-6.
30. Arribas-Gómez I, Duque-Marín I, Pérez de Lema G, et al. A possible role for platelet-activating factor in the hydrogen peroxide-induced TxB2 and PGE2 glomerular synthesis. J Lipid Res 1995;36:260-5.
31. Misra RP. Isolation of glomerular from mammalian kidneys by graded sieving. Am J Clin Pathol 1972;58:135-9.
32. Gonzalez J, Villafruela JJ, Sabater J, et al. Determination of urinary immunorreactive thromboxane B2 by radioimmunoassay after a simple extraction step. Bioquímica Clínica 1988; 12:666-70.
33. Lowry OH, Rosebrough NG, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Che. 1951; 193:265-9.
34. Gutteridge JM, Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci 1990;15:129-34.
35. Mayo LA. Oxygen radicals and antioxidants. In: Parker L, Glazer AN, editors. Methods in enzymology, Vol.186. London: Academic Press;1990:567-75.
36. Baud L, Pérez J, Ardaillou R. Dexamethasone and hydrogen peroxide production by mesangial cells during phagocitosis. Am J Physiol 1986;250: F596-604.
37. Cheeseman KH, Slater TF, editors. Free radicals in medicine. Br Med Bull 1993;49(3):479-724.
38. Shibouta Y, Terashita ZI, Imura Y, et al. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats. Kidney Int 1991;39:920-9.
39. Nath K, Salahudeen AK. Induction of renal growth and injury in the rat kidney by dietary deficiency of antioxidants. J Clin Invest 1990;86:1179-92.
40. Betschart JM, Virji MA, Shinozuka H. Cyclosporine A-induced alteratins in rat hepatic glycogen metabolism. Transplant Proc 1988;20(Suppl 3):880-4.
41. Walker RJ, Lazzaro VA, Duggin GG, et al. Evidence that alterations in renal metabolism and lipid peroxidation may contribute to cyclosporine nephrotoxicity. Transplantation 1990; 50:487-92.
42. Ahmed SS, Strobel HW, Napoli KL, Grevel J. Adreno-chrome reaction implicates oxygen radicals in metabolism of cyclosporine A and FK-506 in rat and human liver microsomes. J Pharmacol Exp Ther 1993;265:1047-54.
43. Diederich D, Skopec J, Diederich A, Dai FX. Cyclosporine produces endothelial dysfunction by increased production of superoxide. Hypertension 1994;23(6 Pt 2):957-61.
44. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. J Clin Invest 1992;90: 2502-7.
45. Baud L, Ardaillou R. Involvement of reactive oxygen species in kidney damage. Br Med Bull 1993;49(3):621-9.
46. Bonventre JV. Mechanisms of ischemic renal failure. Kidney Int 1993;43:1160-78.
47. Halevy O, Sklan D. Inhibition of arachidonic acid oxidation by beta-carotene, retinol and alpha-tocopherol. Biochim Biophys Acta 1987;918(3):304-7.
48. +-adenosine triphosphatase activity in cultured hamster renal tubular cells. Toxicol Appl Pharmacol 1994;125:176-83.
49. Cook T. Nitric oxide synthases and the role of nitric oxide in acute renal failure. In: Goligorsky MS, Stein JS, editors. Acute renal failure: new concepts and therapeutic strategies. New York: Churchill Livingstone, 1995:119-42.